142 related articles for article (PubMed ID: 37996734)
21. Anterior segment optical coherence tomography features of pseudoepitheliomatous hyperplasia of the ocular surface: a study of 9 lesions.
Kaliki S; Maniar A; Jakati S; Mishra DK
Int Ophthalmol; 2021 Jan; 41(1):113-119. PubMed ID: 32839863
[TBL] [Abstract][Full Text] [Related]
22. Predictive index to differentiate invasive squamous cell carcinoma from preinvasive ocular surface lesions by impression cytology.
Barros JN; Lowen MS; Ballalai PL; Mascaro VL; Gomes JA; Martins MC
Br J Ophthalmol; 2009 Feb; 93(2):209-14. PubMed ID: 19019933
[TBL] [Abstract][Full Text] [Related]
23. Comparative evaluation of clinical characteristics of biopsy-proven conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma using image processing software programs.
Vempuluru VS; Kapoor AG; Kaliki S; Jajapuram SD; Mohamed A; Mishra DK
Int Ophthalmol; 2021 Apr; 41(4):1301-1307. PubMed ID: 33392945
[TBL] [Abstract][Full Text] [Related]
24. Case Series: High-resolution Optical Coherence Tomography as an Optical Biopsy in Ocular Surface Squamous Neoplasia.
Aboumourad RJ; Galor A; Karp CL
Optom Vis Sci; 2021 May; 98(5):450-455. PubMed ID: 33967253
[TBL] [Abstract][Full Text] [Related]
25. Conjunctival Lesions: A 5-Year Basic Demographic Data and Clinicopathological Review in a Tertiary Eye Care Hospital.
Alkatan HM; Alshomar KM; Helmi HA; Alhothali WM; Alshalan AM
J Epidemiol Glob Health; 2022 Mar; 12(1):25-39. PubMed ID: 34846715
[TBL] [Abstract][Full Text] [Related]
26. Exfoliative Cytology in the Diagnosis of Ocular Surface Squamous Neoplasms.
Kayat KV; Correa Dantas PE; Felberg S; Galvão MA; Saieg MA
Cornea; 2017 Jan; 36(1):127-130. PubMed ID: 27661075
[TBL] [Abstract][Full Text] [Related]
27. Spontaneous regression of presumed ocular surface squamous neoplasia: A report of 8 cases.
Vempuluru VS; Ghose N; Vithalani NM; Sultana S; Kaliki S
Eur J Ophthalmol; 2022 Sep; 32(5):3029-3034. PubMed ID: 34747253
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.
Walsh T; Macey R; Kerr AR; Lingen MW; Ogden GR; Warnakulasuriya S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD010276. PubMed ID: 34282854
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological review of ocular surface squamous neoplasia in Malawi.
Tiong T; Borooah S; Msosa J; Dean W; Smith C; Kambewa E; Kiire C; Zondervan M; Aspinall P; Dhillon B
Br J Ophthalmol; 2013 Aug; 97(8):961-4. PubMed ID: 23613511
[TBL] [Abstract][Full Text] [Related]
30. Preoperative brush and impression cytology in ocular surface squamous neoplasms.
Ersöz C; Yağmur M; Ersöz TR; Yalaz M
Acta Cytol; 2003; 47(1):13-5. PubMed ID: 12585025
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and Medical Management of Ocular Surface Squamous Neoplasia.
Sayed-Ahmed IO; Palioura S; Galor A; Karp CL
Expert Rev Ophthalmol; 2017; 12(1):11-19. PubMed ID: 28184236
[TBL] [Abstract][Full Text] [Related]
32. Role of high resolution optical coherence tomography in diagnosing ocular surface squamous neoplasia with coexisting ocular surface diseases.
Atallah M; Joag M; Galor A; Amescua G; Nanji A; Wang J; Perez VL; Dubovy S; Karp CL
Ocul Surf; 2017 Oct; 15(4):688-695. PubMed ID: 28347855
[TBL] [Abstract][Full Text] [Related]
33. Assessing Profile and Treatment Outcome in Patients of Ocular Surface Squamous Neoplasia (OSSN).
Shrestha E; Banstola L; Man I; Gurung B; Gurung H; Adhikari HB
Nepal J Ophthalmol; 2019 Jul; 11(22):181-188. PubMed ID: 32792695
[TBL] [Abstract][Full Text] [Related]
34. Extending far and wide: the role of biopsy and staging in the management of ocular surface squamous neoplasia.
Polski A; Sibug Saber M; Kim JW; Berry JL
Clin Exp Ophthalmol; 2019 Mar; 47(2):193-200. PubMed ID: 30156057
[TBL] [Abstract][Full Text] [Related]
35. The use of 1% toluidine blue eye drops in the diagnosis of ocular surface squamous neoplasia.
Romero IL; Barros Jde N; Martins MC; Ballalai PL
Cornea; 2013 Jan; 32(1):36-9. PubMed ID: 22525782
[TBL] [Abstract][Full Text] [Related]
36. American Joint Committee on Cancer Staging and clinicopathological high-risk predictors of ocular surface squamous neoplasia: a study from a tertiary eye center in India.
Chauhan S; Sen S; Sharma A; Tandon R; Kashyap S; Pushker N; Vanathi M; Sharma N
Arch Pathol Lab Med; 2014 Nov; 138(11):1488-94. PubMed ID: 25357110
[TBL] [Abstract][Full Text] [Related]
37. Ocular Surface Squamous Neoplasia Following Keratoplasty in Xeroderma Pigmentosa: A Series of Seven Cases.
Vempuluru VS; Ganguly A; Kaliki S
Curr Eye Res; 2021 Nov; 46(11):1631-1636. PubMed ID: 33908328
[No Abstract] [Full Text] [Related]
38. Optical coherence tomography angiography in the evaluation of vascular patterns of ocular surface squamous neoplasia during topical medical treatment.
Theotoka D; Liu Z; Wall S; Galor A; Al Bayyat GJ; Feuer W; Jianhua W; Karp CL
Ocul Surf; 2022 Jul; 25():8-18. PubMed ID: 35358712
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological characteristics of ocular surface squamous neoplasia: a 10-year review form a referral tertiary centre in Nigeria.
Suleiman DE; Liman AA; Waziri GD; Iliyasu Y; Ahmed SA
Int Ophthalmol; 2022 Dec; 42(12):3905-3911. PubMed ID: 35802299
[TBL] [Abstract][Full Text] [Related]
40. The diagnostic value of exfoliative cytology vs histopathology for ocular surface squamous neoplasia.
Semenova EA; Milman T; Finger PT; Natesh S; Kurli M; Schneider S; Iacob CE; McCormick SA
Am J Ophthalmol; 2009 Nov; 148(5):772-778.e1. PubMed ID: 19660734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]